Skip to main content
Medmira Inc. logo

Medmira Inc. — Investor Relations & Filings

Ticker · MIR ISIN · CA58501R1029 LEI · 984500BA0ETB71CBCB46 TSXV Manufacturing
Open in API
Filings indexed 139 across all filing types
Latest filing 2026-04-02 Regulatory Filings
Country CA Canada
Listing TSXV MIR

About Medmira Inc.

https://www.medmira.ca/

Medmira Inc. is a biotechnology company specializing in the research, development, and manufacturing of rapid diagnostic solutions. The company utilizes its patented Rapid Vertical Flow (RVF) Technology to produce high-quality, in vitro flow-through rapid tests known for speed, accuracy, and multiplexing capabilities. These diagnostic tools provide instant results for infectious diseases, including HIV, Syphilis, Hepatitis B and C, and COVID-19. Medmira's systems are designed for use in hospitals, laboratories, clinics, and by individuals, offering both qualitative and unique quantitative diagnostic results in minutes.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” under Canadian NI 52-109, consisting solely of officer certifications regarding the interim financial report and interim MD&A. It is not the interim report itself (IR), nor an earnings release, management discussion, or investor presentation, but a required regulatory form. There is no dedicated category for certification statements, so this falls under the general “Regulatory Filings” (RNS) fallback.
2026-04-02 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a CSA Form 52-109FV2 “Venture Issuer Basic Certificate” whereby the CFO certifies the interim financial report and interim MD&A. It is not the interim report or MD&A itself (no financial statements or discussion text), nor an announcement of publication timing; rather it is a regulatory filing certification form. There is no dedicated category for certification forms, so it falls under the fallback “Regulatory Filings” (RNS).
2026-04-02 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Condensed Interim Consolidated Financial Statements' for MedMira Inc. for the six-month period ended January 31, 2026. It contains comprehensive financial statements (Statement of Financial Position, Statement of Operations, Statement of Changes in Equity, Statement of Cash Flows) and detailed notes to the financial statements. This meets the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. H1 2026
2026-04-02 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled 'Management’s Discussion & Analysis' for the six months ended January 31, 2026. It provides a detailed narrative explanation of the company's financial performance, business trends, strategic direction, and operational outlook. This aligns perfectly with the definition of a Management's Discussion and Analysis (MDA) report, which is a core component of interim financial reporting and management commentary. H1 2026
2026-04-02 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a press release dated April 1, 2026 announcing MedMira’s second quarter fiscal 2026 financial results, including revenue, profit and loss highlights, balance sheet summaries, and forward‐looking statements. It is an initial summary announcement of quarterly financial performance rather than a full interim report. This matches the definition of an Earnings Release (ER). Q2 2026
2026-04-02 English
Notice of the meeting and record date (amended) - French.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a notice from the transfer agent to Canadian securities regulators providing details about an upcoming Annual General Meeting (AGM) of Medmira Inc. It specifies the type of meeting, record dates for voting, meeting date and location, and share details – all elements used to solicit proxies or inform shareholders for voting. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI).
2026-01-21 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.